文献速递肝病消化道肿瘤与早癌

NCACC绘制跨样本空间生态位并揭示cIgG+上皮稀有细胞驱动肝癌侵袭

NCACC maps cross-sample spatial niches and reveals cIgG+ epithelial rare cells driving liver cancer invasion.
PubMed 文献 · Gut · 2026-09-11

研究开发了NCACC双层框架,整合空间组织与细胞组成以跨样本发现生态位,并应用于肝癌转录组图谱。NCACC将肝癌结构分层为可重复的多细胞生态位模块,识别出富集于肿瘤侵袭前沿的cIgG+上皮稀有细胞,其增强增殖侵袭并与疾病进展相关。机制分析发现STAT1依赖的cIgG-JAK-STAT信号轴维持侵袭前沿表型,结构引导虚拟筛选联合类器官验证提示去甲二氢愈创木酸和没食子醛为候选调节剂。

要点

  • NCACC可跨异质性空间转录组队列高置信度识别稀有恶性细胞。
  • cIgG+上皮细胞富集于侵袭前沿,增强增殖侵袭并与疾病进展相关。
  • cIgG-JAK-STAT轴为肝癌侵袭的可靶向驱动通路,候选调节剂经类器官验证。

核心结论

  • NCACC是跨异质性空间转录组队列高置信度识别稀有恶性细胞的通用框架。
  • cIgG-JAK-STAT是肝癌侵袭的可靶向驱动通路。

研究设计与样本

  • 开发NCACC双层框架,整合空间组织与细胞组成以跨样本发现生态位。
  • 将NCACC应用于综合肝癌转录组图谱以识别稀有生态位相关恶性细胞。
  • 结合结构引导虚拟筛选与患者来源类器官验证候选调节剂。

主要发现

  • NCACC将肝癌肿瘤结构分层为可重复的多细胞生态位模块。
  • 识别出肿瘤侵袭前沿富集的cIgG+上皮稀有细胞群体。
  • cIgG+上皮细胞增强增殖和侵袭特征,并与疾病进展相关。
  • 机制分析发现STAT1依赖的cIgG-JAK-STAT信号轴维持侵袭前沿表型并促进cIgG+上皮细胞侵袭行为。
  • 虚拟筛选联合类器官验证鉴定去甲二氢愈创木酸和没食子醛为候选调节剂。

临床怎么用

  • NCACC可用于跨样本空间转录组数据中稀有恶性细胞的高置信度识别。
  • cIgG-JAK-STAT轴可作为肝癌侵袭的潜在治疗靶点。
  • 去甲二氢愈创木酸和没食子醛为经类器官验证的候选调节剂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Liver cancer exhibits profound spatial and cellular heterogeneity, contributing to tumour progression, invasion and therapeutic resistance. Emerging evidence suggests that rare low-abundance malignant cell populations residing within discrete tissue niches influence these processes. However, their reliable detection and identification remain challenging due to the limitations of conventional spatial and single-cell transcriptomic analyses, which often rely on single-sample convergence and a lack of cross-cohort reproducibility. OBJECTIVE: To develop a robust framework for identifying rare malignant cell populations across heterogeneous spatial transcriptomic datasets and to characterise their functional role in liver cancer progression. DESIGN: We developed the Niche Cluster Atlas with Cellular Co-localisation (NCACC), a dual-layer framework integrating spatial organisation with cellular composition to enable cross-sample niche discovery. NCACC was applied to a comprehensive liver cancer transcriptomic atlas to identify rare niche-associated malignant cell populations. RESULTS: NCACC stratified liver cancer tumour architecture into reproducible multicellular niche modules and enabled a tumour-invasive front-enriched rare cancer-derived IgG (cIgG)+ epithelial cell population. These cells enhanced proliferative and invasive characteristics and were associated with disease progression. Mechanistic analyses identified a STAT1-dependent cIgG-JAK-STAT signalling axis sustaining the invasive-front phenotype and promoting cIgG+ epithelial cell aggressive behaviours. We then combined structure-guided virtual screening with patient-derived organoid validation to identify nordihydroguaiaretic acid and gallic aldehyde as candidate modulators. CONCLUSION: Our study establishes NCACC as a generalisable framework for high-confidence rare malignant cell identification across heterogeneous spatial transcriptomic cohorts, highlighting the cIgG-JAK-STAT as a therapeutically actionable driver of liver cancer invasion.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Hai C, Hou Y, Yu S, et al. NCACC maps cross-sample spatial niches and reveals cIgG+ epithelial rare cells driving liver cancer invasion. Gut. 2026. PMID: 42728030. doi:10.1136/gutjnl-2026-338471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。